Annexon (ANNX) Retained Earnings (2019 - 2026)
Annexon's (ANNX) quarterly Retained Earnings came in at $1.2 billion in Q1 2026, up 1281400.0% year-on-year from N/an in Q1 2025, and up 4020731.03% quarter-over-quarter from -$29000.0 in Q4 2025.
Annexon (ANNX) Retained Earnings (2019 - 2026) Analysis & Trends
Annexon's Retained Earnings history runs 8 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- On a quarterly basis, Retained Earnings rose 1281400.0% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 1281400.0% increase from a year earlier, with the FY2025 full-year figure at -$29000.0, up 100.0% from the prior year.
- Retained Earnings rose to $1.2 billion in Q1 2026 per ANNX's latest filing, from -$29000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $1.2 billion in Q1 2026 and bottomed at -$869.1 million in Q3 2025.
- The 5-year median for Retained Earnings is -$368.8 million (2022), against an average of -$213.9 million.
- Across the five-year window, Retained Earnings sank 914731.46% in 2025 and jumped 1281400.0% in 2026, its largest moves.
- Year by year, Retained Earnings stood at -$438.3 million in 2022, then sank by 30.63% to -$572.5 million in 2023, then slipped by 24.14% to -$710.7 million in 2024, then surged by 100.0% to -$29000.0 in 2025, then surged by 4020731.03% to $1.2 billion in 2026.
- Per Business Quant, the three latest ANNX Retained Earnings figures stand at $1.2 billion (Q1 2026), -$29000.0 (Q4 2025), and -$869.1 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | -869.10 Mn |
| Jun 30, 2025 | -814.20 Mn |
| Mar 31, 2025 | -91,000.00 |
| Dec 31, 2024 | -710.70 Mn |
| Sep 30, 2024 | -662.10 Mn |
| Jun 30, 2024 | -89,000.00 |
| Mar 31, 2024 | -102,000.00 |
| Dec 31, 2023 | -572.50 Mn |
| Sep 30, 2023 | -544.60 Mn |
| Jun 30, 2023 | -512.10 Mn |
| Mar 31, 2023 | 691.96 Mn |
| Dec 31, 2022 | -438.26 Mn |
| Sep 30, 2022 | -406,000.00 |
| Jun 30, 2022 | -368.80 Mn |
| Mar 31, 2022 | -373,000.00 |
| Dec 31, 2021 | 528.37 Mn |
| Sep 30, 2021 | -75,000.00 |
| Jun 30, 2021 | -65,000.00 |